Medical events and costs associated with metabolic bariatric surgery among adults with type 2 diabetes: A retrospective, matched cohort study
MBS was performed relatively infrequently in adults with T2D + O. Cases, compared with controls, used fewer GLM, had significantly lower post-period all-cause drug costs, and lower rates of incident comorbidities, but had significantly higher post-period all-cause total medical costs and higher rates of medical events.
Authors
- Lisa M. Neff (ORCID: https://orcid.org/0000-0002-3006-6057)
- Maureen J. Lage (ORCID: https://orcid.org/0000-0003-4961-2027)
- Magaly Perez‐Nieves (ORCID: https://orcid.org/0000-0002-6264-1095)
- Kristina Secnik Boye (ORCID: https://orcid.org/0000-0002-5953-5929)
- Krishna Karthik Chivukula (ORCID: https://orcid.org/0000-0002-8732-2779)
Institutions
- Eli Lilly (United States) (US)
- Health Outcomes Solutions (United States) (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1111/dom.70226
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00